Wide Ranks

ATEC

Alphatec Holdings, Inc.

10.37

Top Statistics
Market Cap 1 B Forward PE -43.69 Revenue Growth 27.40 %
Current Ratio 2.32 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -31.06 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -31.57 Enterprise / Revenue 3.45 Price To Sales Trailing12 Months 2.57
Profitability
Profit Margins -31.06 % Operating Margins -20.35 %
Balance Sheet
Total Cash 80 M Total Cash Per Share 0.5710 Total Debt 563 M
Total Debt To Equity 2535.20 Current Ratio 2.32 Book Value Per Share -0.0100
All Measures
Short Ratio 387.00 % Message Board Id finmb_21766771 Fax 800 431 9722
Shares Short Prior Month 12 M Return On Equity -211.37 City Carlsbad
Uuid 6d57fffc-14e0-39e7-8422-343a2c961962 Previous Close 9.61 First Trade Date Epoch Utc 1 B
Book Value -0.0100 Beta 1.31 Total Debt 563 M
Volume 1 M Last Split Date 1 B Fifty Two Week Low 4.88
Total Cash Per Share 0.5710 Total Revenue 572 M Shares Short Previous Month Date 1 B
Target Median Price 17.00 Audit Risk 6 Max Age 86400
Recommendation Mean 1.58 Sand P52 Week Change 0.3133 Operating Margins -20.35 %
Target Mean Price 16.83 Net Income To Common -177868992 Short Percent Of Float 0.0924
Implied Shares Outstanding 141 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 1 M Average Volume10days 1 M Total Cash 80 M
Next Fiscal Year End 1 B Revenue Per Share 4.08 Held Percent Insiders 0.2548
Ebitda Margins -10.93 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Share Holder Rights Risk 4 Regular Market Previous Close 9.61
Target Low Price 9.50 Gmt Off Set Milliseconds -18000000 Fifty Day Average 6.94
Open 9.71 Free Cashflow -125792624 State CA
Dividend Yield 0.00 % Return On Assets -0.1210 Time Zone Short Name EST
Board Risk 8 Trailing Eps -1.26 Day Low 9.70
Address1 1950 Camino Vida Roble Shares Outstanding 141 M Compensation Risk 7
Price Hint 2 Target High Price 22.50 Website https://www.atecspine.com
52 Week Change -0.1264 Average Volume 2 M Forward Eps -0.6500
Recommendation Key buy Compensation As Of Epoch Date 1 B Quick Ratio 105.40 %
Last Split Factor 1:12 Regular Market Day High 10.47 Is_sp_500 False
Profit Margins -31.06 % Debt To Equity 2535.20 Fifty Two Week High 17.34
Day High 10.47 Shares Short 10 M Regular Market Open 9.71
Industry Key medical-devices Earnings Growth 0.00 % Enterprise To Revenue 3.45
Revenue Growth 27.40 % Shares Percent Shares Out 0.0747 Operating Cashflow -80178000
Currency USD Time Zone Full Name America/New_York Market Cap 1 B
Is_nasdaq_100 False Zip 92008 Quote Type EQUITY
Industry Medical Devices Long Name Alphatec Holdings, Inc. Overall Risk 6
Regular Market Day Low 9.70 Held Percent Institutions 0.5793 Current Price 10.37
Enterprise To Ebitda -31.57 Financial Currency USD Current Ratio 2.32
Gross Margins 69.47 % Industry Disp Medical Devices Number Of Analyst Opinions 12
Country United States Float Shares 102 M Two Hundred Day Average 9.81
Governance Epoch Date 1 B Ir Website http://investors.alphatecspine.com/ Price To Sales Trailing12 Months 2.57
Enterprise Value 1 B Forward PE -43.69 Regular Market Volume 1 M
Ebitda -62604000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.

It manufactures and sells implants and instruments through third-party suppliers.

The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.

It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization.

In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications.

The company sells its products through a network of independent sales agents and direct sales representatives.

Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.